Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached an agreement with BeauBrain Healthcare that brings its breakthrough ...
Over the past decade, robotic platforms have become one of the most visible symbols of innovation in spine surgery. Health systems across the country have invested heavily in advanced navigation and ...
C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation(R), has reached an agreement with BeauBrain Healthcare that brings its breakthrough ...
Cardiovascular disease is the leading cause of death in North Carolina, and effective management of the condition is essential to improving residents’ quality of life. Cardiovascular conditions are a ...
Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...
If you’re a Whoop member, you can expect to see two new women’s health updates for both hormonal insights and blood panels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results